Telehealth Integrated Care Model in Patients With Cardiometabolic Disease

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Total Enrollment

1302 participants

Study Classification

OBSERVATIONAL

Study Start Date

2023-06-20

Study Completion Date

2025-07-20

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The objective of this study is to evaluate the telehealth integrated care model for its clinical efficacy, medical resource utilization, health economics measurement, and satisfaction survey indicators in hyperlipidemia patients and other cardiometabolic diseases. The result of the study will provide evidence for the value of integrated model in the treatment of patients with cardiometabolic syndrome.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Using a Telemedicine System to Promote Patient Care Among Underserved Individuals

NCT00644267

Hypertension

UNKNOWN NA

Interdisciplinary Collaborative Care Model Combined With Family Empowerment in Comorbid Hypertension and Diabetes

NCT06998511

Hypertension Diabetes Blood Pressure Control +2 more

COMPLETED NA

Multi-Method Health System Quality Improvement Intervention to Reduce Hypertension Disparities

NCT01566864

Hypertension

COMPLETED NA

Stepped Intervention for Meds Adherence and Blood Pressure Control

NCT00257101

Cardiovascular Diseases Heart Diseases Hypertension

COMPLETED NA

Chronic Disease Health Management Information Platform

NCT04718857

Hypertension

WITHDRAWN

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Efficacy evaluation is critical for understanding the practical application effect of telehealth integrated mode in the therapy of cardiometabolic disease patients. We can comprehend the influence of the combination of online and offline models on patients' clinical curative effect, medication compliance, medical cost, and satisfaction by analyzing the curative effect and finding a scientific basis for clinical practice and policy formation. As a result, the purpose of this study is to assess the curative effect of hyperlipidemia patients with other cardiometabolic disease using a telehealth integrated model, as well as to investigate the potential benefits and risks of this model in the management of cardiometabolic disease.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Cardiometabolic Disease Hyperlipidemia

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Telehealth Integrated Care Group

Followed up in online Internet hospital, estimated and adjusted treatment accroding to clinical efficacy, and send individualized health education messages regularly.

Telehealth integrated care

Intervention Type PROCEDURE

Followed up in online Internet hospital, estimated and adjusted treatment accroding to clinical efficacy, and send individualized health education messages regularly.

Conventional Group

Followed up face-to-face in cardiacmetabolic clinics, estimated and adjusted treatment accroding to clinical efficacy, and conducted health education.

Conventional health care

Intervention Type PROCEDURE

Followed up face-to-face in cardiacmetabolic clinics, estimated and adjusted treatment accroding to clinical efficacy, and conducted health education.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Telehealth integrated care

Followed up in online Internet hospital, estimated and adjusted treatment accroding to clinical efficacy, and send individualized health education messages regularly.

Intervention Type PROCEDURE

Conventional health care

Followed up face-to-face in cardiacmetabolic clinics, estimated and adjusted treatment accroding to clinical efficacy, and conducted health education.

Intervention Type PROCEDURE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Age ≥ 16 years, and ≤ 85 years;
* Diagnosis as hyperlipidemia with at least one of the following disease: hypertension or type 2 diabetes mellitus;
* Agreed to be enrolled in this study.

Exclusion Criteria

* Undergone percutaneous coronary intervention within one year in our hospital;
* Severe LV dysfunction, such as LV ejection fraction \< 35%, or congestive heart failure with New York Heart Association (NYHA) functional class IV or Killip class IV;
* Structural heart disease, or severe arrhythmia;
* Severe liver or kidney diseases, endocrinology diseases, hematologic diseases, rheumatic immune system diseases, and malignancy;
* could not complete at least one-year-followup.

Minimum Eligible Age

16 Years

Maximum Eligible Age

85 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No